Показано 0 из 0
Дата |
---|
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.948
|
2.02
|
1.944
|
1.942
|
1.99
|
1.99
|
|
|
|
|
2.04
|
2.115
|
1.974
|
1.974
|
2.005
|
2.005
|
|
|
|
|
2.055
|
2.135
|
1.87
|
1.87
|
1.892
|
1.892
|
|
|
|
|
1.90
|
1.972
|
1.822
|
1.82
|
1.85
|
1.85
|
|
|
|
|
1.828
|
1.90
|
1.826
|
1.824
|
1.864
|
1.864
|
|
|
|
|
1.848
|
1.918
|
1.844
|
1.844
|
1.87
|
1.87
|
|
|
|
|
1.86
|
1.934
|
1.796
|
1.792
|
1.828
|
1.828
|
|
|
|
|
1.81
|
1.882
|
1.828
|
1.824
|
1.854
|
1.854
|
|
|
|
|
1.834
|
1.904
|
1.924
|
1.924
|
1.962
|
1.962
|
|
|
|
|
1.856
|
1.93
|
1.632
|
1.632
|
1.664
|
1.664
|
|
|
|
|
Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.